FDA approves Octaplas to treat patients with blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels. Clotting protein deficiencies can cause excessive bleeding or excessive clotting.

FDA approves new seasonal influenza vaccine made using novel technology

The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of seasonal influenza in people 18 through 49 years of age.

Belmont Confections Issues Allergy Alert on Undeclared Peanuts in “Dymatize Nutrition, Elite Gourmet Bars” (Cookies & Cream and Fudge Brownie)

Belmont Confections Inc. is recalling Dymatize Nutrition Elite Gourmet Cookies & Cream bars and Dymatize Nutrition Elite Gourmet Fudge Brownie bars in both the 1.5oz and 3oz packages because they may contain undeclared peanuts. Belmont became aware of the problem via a complaint to the distributor Dymatize Inc.

Boba Direct Issues Allergy Alert on Undeclared Milk in BD Flavored Powders

Boba Direct (BD) announced the voluntary recall of the following BD Flavored Powders: Almond, Avocado, Banana, Blueberry, Café Latte, Cherry, Chocolate, Coconut, Honeydew, Lavender, Lychee, Mango, Matcha Green Tea, Milk Tea, Passionfruit, Peppermint, Pineapple, Red Bean, Strawberry, Taro, Vanilla and Watermelon in the 2.2 lb. plastic bags because of the incorrect label failing to declare milk as the source of sodium caseinate and lactose.  Individuals with allergies to milk run the risk of serious or life-threatening allergic reaction if they consume these products.

FDA requiring lower recommended dose for certain sleep drugs containing zolpidem

The U.S. Food and Drug Administration today announced it is requiring the manufacturers of Ambien, Ambien CR, Edluar and Zolpimist, widely used sleep drugs that contain the active ingredient zolpidem, to lower current recommended doses. Ambien and Ambien CR are also available as generics. New data show that zolpidem blood levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving.